A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Status:
Completed
Trial end date:
2019-06-26
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate how effective and safe the study drug known as
ixekizumab is in participants with active psoriatic arthritis.